Public Company News
Alphamab Oncology Announced First Patient Dosed in the U.S. in A Phase II Pivotal Clinical Study of KN046
SUZHOU, China, Dec. 23, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced dosing of the first patient of its proprietary PD-L1/CTLA-4 bispecific antibody KN046 inthe United States. The patient received treatment in ENREACH-Thymic, a phase II, open label, multi-center pivotal...
2021-12-23 09:13
3856
USI and Symlink Develop an All-In-One Smart POS - eOrder for Self-Service Contactless Shopping
SHANGHAI, Dec. 23, 2021 /PRNewswire/ -- COVID-19 has dramatically changed the way we work, live, consume, and shop. While the world is slowly getting back on track as vaccinations have been widely accepted, maintaining an appropriate social distance, and engaging in contactless consumption are st...
2021-12-23 07:00
5547
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
- Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants - Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG rise...
2021-12-23 05:54
4687
Hyundai Motor Presents Vision of Unlimited Mobility Enabled by Robotics and Metaverse at CES 2022
* Hyundai Motor to share its future vision for robotics and the metaverse under the main theme of 'Expanding Human Reach', building on its idea of a future mobility ecosystem * Mobility of Things (MoT) concept to be revealed, enabling the autonomous movement of traditionally inanimate objects...
2021-12-23 05:00
3491
Risen Energy hits new record of 23.65% in heterojunction module efficiency
NINGBO, China, Dec. 23, 2021 /PRNewswire/ -- Risen Energy Co., Ltd ("Risen Energy") has recently announced that TÜV Rheinland, a world-leading third-party testing and certification organization, confirmed that its high-efficiency heterojunction module series have achieved a maximum power of 721.0...
2021-12-23 02:00
4924
Sungrow Is Following The Way For Green Christmas Campaign: Plant Trees For A Cleaner Future
MUNICH, Dec. 22, 2021 /PRNewswire/ -- Sungrow, the global leading inverter solution supplier for renewables, announced recently it became the official partner of the non-profit foundation Plant-My-Tree to broaden its contribution to a greener and more sustainable planet with action taken to refor...
2021-12-22 17:51
2571
Commercial breakthrough is in the cards for Zwipe
- Season's Greetings from André Løvestam, CEO of Zwipe OSLO, Norway, Dec. 22, 2021 /PRNewswire/ --With our eyes set on the long-awaited commercial breakthrough for Zwipe which now seems highly likely to happen in 2022, we have spent the last four years undergoing a transformation which has laid ...
2021-12-22 17:43
2876
Clarivate Acquires Patient Connect, Furthering Position as a Leading Provider of Patient-Centric Solutions
Expanded global offerings allow life science companies to make confident, data-driven decisions tailored to their patient populations LONDON, Dec. 22, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovatio...
2021-12-22 16:00
6151
How Global Fortune 500 Companies Approach Connectivity and IoT with Tuya Smart
SANTA CLARA, Calif., Dec. 22, 2021 /PRNewswire/ -- Tuya Smart ("Tuya" or the "Company") (NYSE: TUYA) a global IoT development platform service provider, hosted executives from Orange, the world-leading telecom provider and Sharp Consumer Electronics Europe ("Sharp Europe"), the worldwide develope...
2021-12-22 14:42
2957
GoodWe: Inverter technology continuous breakthrough Empower solar energy
MANILA, Philippines, Dec. 22, 2021 /PRNewswire/ -- To achieve the dream of the world net zero emission by 2025, accelerating the energy transition and revolution have become inevitable. At the same time, with the rapid economic development and unit cost of silicon-basedphotovoltaic cells declinin...
2021-12-22 12:30
3359
GoodWe sees a bright future in building sustainable SEA cities
JAKARTA, Indonesia, Dec. 22, 2021 /PRNewswire/ -- For the past decades, Southeast Asia (SEA) has seen rapid economic growth, with countries such as Singapore marking their position as part of the largest economies in the world and some of the fastest-growing economies. However, this notable growt...
2021-12-22 11:54
3869
Toshiba's Transparent Cu2O Tandem Solar Top Cell Achieves 8.4% Efficiency
TOKYO, Dec. 22, 2021 /PRNewswire/ -- Toshiba Corporation (TOKYO: 6502) today announced that it has successfully raised the power conversion efficiency (PCE) of its transparent Cu2O solar cell to 8.4%, the world's highest level for a reported Cu2O solar cell*1. With the cell positioned as the top ...
2021-12-22 10:00
3906
Marriott International Signs Agreement with Melco Resorts & Entertainment to Bring Macau's First W Hotel
SHANGHAI, Dec. 22, 2021 /PRNewswire/ -- Marriott International, Inc. today announced that it has signed an agreement with Melco Resorts & Entertainment to bring the W Hotels Worldwide brand toMacau. Scheduled to open in December 2022, W Macau – Studio City is expected to become an iconic addition...
2021-12-22 10:00
8819
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories
- Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications inEurope (including theUnited Kingdom), Latin America and Other Key Countries - Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202...
2021-12-22 09:39
4456
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine
- WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older - SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emerg...
2021-12-22 09:31
4901
Ortoma Signs Agreement for Exclusive Distribution Rights in Japan
STOCKHOLM, Dec. 22, 2021 /PRNewswire/ -- Ortoma signs agreement with Johnson & Johnson K.K. for exclusive distribution rights inJapan of the Ortoma Treatment Solution for hip surgery. It is the first agreement that the company executes with a global strategic partner. The agreement allows for the...
2021-12-22 09:30
3149
Landis+Gyr Divests Stake in Intellihub Joint Venture
CHAM, Switzerland and SYDNEY, Dec. 22, 2021 /PRNewswire/ -- Landis+Gyr Group AG (SIX: LAND), a leading provider of integrated energy management solutions, today announced that its subsidiary Landis+Gyr Pty Ltd. has entered into an agreement to sell its ownership in Intellihub Operations Pty Ltd (...
2021-12-22 06:38
5296
MINISO marks milestone in Boston with 5,000th store globally; $10 N' Under concept wins over Gen Z with trendy experiences
BOSTON, Dec. 21, 2021 /PRNewswire/ -- After growing at breakneck speed for several years, lifestyle retailer MINISO has hit yet another milestone. On December 18, the brand's 5,000th store opened in Boston, Massachusetts, bringing its variety of affordable plush toys and household items to the New...
2021-12-21 22:08
4838
Ping An Good Doctor and Chugai Pharma China Jointly Establish a Whole Course Management System for Osteoporosis Patients
HONG KONG and SHANGHAI, Dec. 21, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 1833.HK) announced that it had entered into a strategic partnership with a leading Japanese pharmaceutical company, Chugai Pharma China Co., Ltd., ("Chugai P...
2021-12-21 17:57
3819
CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER
SUZHOU, China, Dec. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals (the " Company" or "CStone") is pleased to announce that the National Medical Products Administration ("NMPA") of China has approved the new drug application ("NDA") of anti-PD-L1 monoclonal antibody Cejemly® (sugemalimab) in comb...
2021-12-21 16:56
5090
Week's Top Stories
Most Reposted
Carro secures strategic investment from Orico
[Picked up by 295 media titles]
2026-09-18 16:29CityUHK and University of Cambridge establish Centre for Advanced and Smart Manufacturing to shape Hong Kong's Industry 5.0 future
[Picked up by 289 media titles]
2026-09-22 18:37
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
[Picked up by 281 media titles]
2026-09-17 13:09
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 276 media titles]
2026-09-23 09:00
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 273 media titles]
2026-09-21 08:00Most Read
COSRX Brings Its 5 Peptide Lip Collection to Ulta Beauty Stores Offline
2026-09-18 22:00
10800
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
2026-09-17 13:09
9931
Ohmyhome Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
2026-09-17 20:00
8140
American Savings Bank Jumps More Than 6% in Trading Debut: NYSE Content Update
2026-09-17 21:21
7722
Sea, Gardens, Lawns and Hearths: Life Abroad Across Noah's N+ Club Network
2026-09-18 23:04
7012